Biocompounding
3 Top Biotech News Of The Week (27 August 22)
1. Kymera raises $150 million through the sale of shares to fund development of its clinical and preclinical assets
Kymera which focuses on targeted protein degradation announced that it is raising $150 million to support its ongoing research and development programs and for general corporate purposes.
The biotech has three
3 Top Biotech News Of The Week (20 August 22)
1. Merck makes big R&D investment with $3.5B Orna deal
ORNA Therapeutics recently struck a deal with Merck to collaborate on the advancement of Orna’s Next Generation of RNA Technology.
What does ORNA Therapeutics do?
In the next revolution in RNA therapeutics, oRNA molecules are engineered
3 Top Biotech News Of The Week (13 August 22)
1) Pfizer's acquisition of Global Blood Therapeutics
The acquisitions continue!
This week Pfizer reported that it will be acquiring Global Blood Therapeutics (GBT) for $5.4B.
The proposed acquisition is expected to drive growth by bringing GBT's sickle cell disease (SCD) expertise together with a robust
3 Top Biotech News Of The Week (6 August 22)
1) Beam served with clinical hold for Beam-201
$BEAM announced an FDA clinical hold on Beam-201, its multiplex silenced CD7 CAR-T asset. Beam-201 is an ex-vivo T-cell therapy being developed for relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) and T-cell lymphoblastic lymphoma. $BEAM uses its base editing technology to prepare
3 Top Biotech News Of The Week (30 July 22)
On Wednesday, the Federal Reserve raised interest rates by 75 basis points, at the same time, however, stocks closed the week higher with S&P 500 posting the best month since 2020.
The biotech sector on the other hand had a relatively flat week, with the $XBI index rising
